Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 6
Submit an article Journal homepage
8,413
Views
19
CrossRef citations to date
0
Altmetric
Diabetes

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis

B. B. HansenNovo Nordisk A/S, Søborg, Denmark;
,
S. NuhohoNovo Nordisk A/S, Søborg, Denmark; ORCID Iconhttp://orcid.org/0000-0001-7061-0101
ORCID Icon,
S. N. AliNovo Nordisk Inc, Plainsboro, NJ, USA;
,
T. Dang-TanNovo Nordisk Inc, Plainsboro, NJ, USA;
,
W. J. ValentineOssian Health Economics and Communications, Basel, Switzerland
,
S. J. P. MalkinOssian Health Economics and Communications, Basel, Switzerland
&
B. HuntOssian Health Economics and Communications, Basel, SwitzerlandCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5420-279X
ORCID Icon show all
Pages 650-658 | Received 01 Nov 2019, Accepted 24 Jan 2020, Published online: 07 Feb 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.